市場調査レポート

商品コード

1520624

動物用疼痛管理の世界市場の評価：製品タイプ別、用途別、動物タイプ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Veterinary Pain Management Market Assessment, By Product, By Application, By Animal Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年07月25日
発行: Market Xcel - Markets and Data
ページ情報: 英文 231 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 648,270円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 821,142円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,181,292円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の動物用疼痛管理の市場規模は、予測期間の2024年～2031年に6.36%のCAGRで拡大し、2023年の18億5,000万米ドルから2031年には30億4,000万米ドルに成長すると予測されています。同市場はかなりの成長を遂げており、今後さらに多様な拡大が見込まれることから、有益な投資機会としての可能性が示されています。

動物の苦痛を和らげ、快適さと生活の質を確保するために用いられるプロセスや療法は、動物用疼痛管理と呼ばれます。鎮痛剤、抗炎症剤、理学療法、鍼治療やレーザー治療のような代替療法の使用による、手術、慢性疾患、怪我、その他の病状によってもたらされる疼痛の管理を含む、幅広い用途が含まれます。動物が快適で苦痛を感じないようにするため、飼い主は動物福祉をより意識するようになり、疼痛管理製品やサービスの需要が高まっています。

しかし、多くの飼い主は、ペットの苦痛を管理することの重要性をまだ認識していません。このような無知は、過小診断や過小治療を招き、ペットの健康を害する可能性があります。ペットの飼い主は、特に低開発地域では、比較的高価なため、獣医学的疼痛管理グッズやサービスを購入することが難しいかもしれません。鎮痛剤の中には、動物にとって危険な悪影響を及ぼすものもあります。獣医業界では疼痛管理の専門家が不足しており、専門的な疼痛管理サービスへのアクセスが制限される可能性があります。動物用疼痛管理薬の開発・承認には厳しい規制基準を満たす必要があり、これには費用と時間がかかります。ペットの飼い主は、鍼治療や漢方薬など、従来の疼痛管理グッズやサービスよりも代替療法を好み始めています。これは市場拡大にプラスに働くかもしれないです。獣医師による疼痛管理には多くの利点があり、動物の健康と幸福を守るために極めて重要です。

動物用疼痛治療市場は、世界のペット飼育の動向により拡大しています。ペットを飼う家庭の増加に伴い、動物医療サービス、特に疼痛管理のニーズが高まっています。動物の健康と福祉に対する飼い主の意識が高まった結果、急性および慢性の疼痛障害について獣医師を頼る人が増えています。このような知識の増加の結果、定期的に動物病院を受診する人が増えており、そのため、疼痛管理が頻繁に注目されるようになっています。効果的な疼痛管理は、ペットの関節炎、手術痛、加齢に伴う不快感などの症状に対して必要です。その結果、動物病院や診療所は、薬物療法から理学療法まで、提供する疼痛治療の範囲を広げています。

当レポートでは、世界の動物用疼痛管理市場について調査し、市場の概要とともに、製品タイプ別、用途別、動物タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

市場のリーダー上位5社の競合マトリックス
主要参入企業トップ5のSWOT分析
市場主要参入企業トップ10の情勢
- Zoetis Services LLC
- Boehringer Ingelheim Animal Health USA Inc.
- Vetoquinol
- Dechra Veterinary Products Limited
- Merck & Co., Inc.
- Ceva Sante Animale
- Norbrook Laboratories Limited
- Chanelle Pharma Group Ltd.
- Fear Free, LLC
- Elanco

第22章戦略的提言

第23章お問い合わせと免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 4. Global Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 5. Global Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 6. Global Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 7. Global Veterinary Pain Management Market Share (%), By Region, 2017-2031F
Figure 8. North America Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 10. North America Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 11. North America Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 12. North America Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 13. North America Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 14. North America Veterinary Pain Management Market Share (%), By Country, 2017-2031F
Figure 15. United States Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 17. United States Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 18. United States Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 19. United States Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 20. United States Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 23. Canada Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 24. Canada Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 25. Canada Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 26. Canada Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 29. Mexico Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 30. Mexico Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 31. Mexico Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 32. Mexico Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 35. Europe Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 36. Europe Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 37. Europe Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 38. Europe Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Veterinary Pain Management Market Share (%), By Country, 2017-2031F
Figure 40. Germany Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 42. Germany Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 43. Germany Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 44. Germany Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 45. Germany Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 46. France Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 48. France Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 49. France Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 50. France Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 51. France Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 54. Italy Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 55. Italy Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 56. Italy Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 57. Italy Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 60. United Kingdom Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 61. United Kingdom Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 62. United Kingdom Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 63. United Kingdom Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 66. Russia Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 67. Russia Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 68. Russia Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 69. Russia Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 72. Netherlands Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 73. Netherlands Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 74. Netherlands Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 75. Netherlands Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 78. Spain Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 79. Spain Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 80. Spain Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 81. Spain Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 84. Turkey Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 85. Turkey Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 86. Turkey Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 87. Turkey Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 90. Poland Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 91. Poland Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 92. Poland Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 93. Poland Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 94. South America Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 96. South America Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 97. South America Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 98. South America Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 99. South America Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 100. South America Veterinary Pain Management Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 103. Brazil Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 104. Brazil Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 105. Brazil Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 106. Brazil Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 109. Argentina Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 110. Argentina Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 111. Argentina Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 112. Argentina Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 115. Asia-Pacific Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 116. Asia-Pacific Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 117. Asia-Pacific Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 118. Asia-Pacific Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Veterinary Pain Management Market Share (%), By Country, 2017-2031F
Figure 120. India Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 122. India Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 123. India Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 124. India Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 125. India Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 126. China Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 128. China Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 129. China Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 130. China Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 131. China Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 134. Japan Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 135. Japan Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 136. Japan Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 137. Japan Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 140. Australia Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 141. Australia Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 142. Australia Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 143. Australia Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 146. Vietnam Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 147. Vietnam Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 148. Vietnam Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 149. Vietnam Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 152. South Korea Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 153. South Korea Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 154. South Korea Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 155. South Korea Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 158. Indonesia Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 159. Indonesia Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 160. Indonesia Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 161. Indonesia Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 164. Philippines Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 165. Philippines Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 166. Philippines Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 167. Philippines Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 170. Middle East & Africa Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 171. Middle East & Africa Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 172. Middle East & Africa Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 173. Middle East & Africa Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Veterinary Pain Management Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 177. Saudi Arabia Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 178. Saudi Arabia Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 179. Saudi Arabia Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 180. Saudi Arabia Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 183. UAE Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 184. UAE Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 185. UAE Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 186. UAE Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Veterinary Pain Management Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Veterinary Pain Management Market, By Volume, In Million Units, 2017-2031F
Figure 189. South Africa Veterinary Pain Management Market Share (%), By Product, 2017-2031F
Figure 190. South Africa Veterinary Pain Management Market Share (%), By Application, 2017-2031F
Figure 191. South Africa Veterinary Pain Management Market Share (%), By Animal Type, 2017-2031F
Figure 192. South Africa Veterinary Pain Management Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11646

Global veterinary pain management market is projected to witness a CAGR of 6.36% during the forecast period 2024-2031, growing from USD 1.85 billion in 2023 to USD 3.04 billion in 2031. The market has seen considerable growth and is poised for further manifold expansion in the future, indicating its potential as a profitable investment opportunity. The processes and therapies used to relieve pain in animals while ensuring their comfort and quality of life is referred to as veterinary pain management. It encompasses a broad range of uses, including the management of pain brought on by surgeries, chronic illnesses, injuries, and other medical conditions through the use of analgesics, anti-inflammatory drugs, physical therapy, and alternative therapies like acupuncture and laser therapy. In order to keep their animals comfortable and pain-free, pet owners are becoming more conscious of animal welfare, which has raised demand for pain management products and services. Still, a lot of pet owners do not yet realize the importance of managing their pets' suffering. This ignorance may result in underdiagnosis and undertreatment, which could be detrimental to their pet's health. Pet owners may find it difficult to afford veterinary pain management goods and services, especially in underdeveloped regions, due to their comparatively high cost. Certain painkillers may have adverse consequences that are dangerous to animals. The veterinary industry is experiencing a scarcity of pain management professionals, which may restrict access to specialized pain management services. Strict regulatory standards must be met for pain management medications intended for veterinary use to be developed and approved, which can be expensive and time-consuming. Pet owners are starting to favor alternative therapies over conventional pain management goods and services, such as acupuncture and herbal medications. This may have a positive effect on market expansion. Veterinarian-assisted pain management has many benefits and is crucial to preserving animal's health and well-being.

As a platinum sponsor, Norbrook Laboratories Limited supported the International Society of Feline Medicine (ISFM) Congress in Dublin in June 2023. Veterinarians and nurses receive the information they need from the International Society of Feline Medicine (ISFM) to effectively address health issues in cats. Their annual congress was held in Dublin, and Norbrook Laboratories Limited was well-represented, emphasizing Thyronorm and Loxicom, their two primary cat products.

Rising Pet Ownership Leading to Market Expansion

The market for veterinary pain treatment is expanding due to the growing trend of pet ownership around the world. The need for veterinary services, particularly pain management, is rising in tandem with the number of households adopting pets. More people are turning to veterinarians for both acute and chronic pain disorders as a result of growing pet owners' awareness of the health and welfare of their animals. There has been an increase in regular veterinary visits as a result of this increased knowledge, and thus, pain management frequently becomes a point of focus. Effective pain management is necessary for conditions like arthritis, surgical pain, and age-related discomfort in pets. As a result, veterinary hospitals and clinics are broadening the scope of pain treatment services they provide, ranging from medication to physical therapy. Additionally, developments in veterinary medicine have enhanced diagnostic capacities, enabling earlier identification and more accurate management of pain. Since there is a deep emotional connection to their dogs, pet owners are prepared to spend money on cutting-edge pain relief techniques in order to prolong the lives of their pets. Innovations in pain management products, such as opioids, nonsteroidal anti-inflammatory medications (NSAIDs), nutraceuticals, and complementary therapies like laser and acupuncture, are also helping the industry. The availability of these varied alternatives gives vets the instruments required to customize pain management programs for specific animals, improving the results of treatment. The humanization of pets, in which animals are considered members of the family, also increases the need for superior veterinarian care. Given that pet owners are looking for thorough and sympathetic care for their animal companions, it is anticipated that this cultural shift will both sustain and accelerate the growth of the veterinary pain treatment industry.

For example, the acquisition of Ethos Veterinary Health by National Veterinary Associates (NVA) Compassion-First, which happened in 2023, illustrates how the expanding pet ownership trend is impacting the veterinary pain care sector. The increased need for specialized veterinary services, including pain management, is reflected through this acquisition. Expanding its offerings to incorporate Ethos's advanced pain management and specialist care, National Veterinary Associates Compassion-First, a network of more than 1,000 veterinary institutions, demonstrated the industry's response to the growing need for comprehensive pet healthcare brought on by the rise in pet ownership.

Huge Investments in Petcare Segment to Spur Market Growth

The veterinary pain management industry is growing at a high rate due to rising investments in pet care. Similar to developments in human healthcare, the demand for advanced healthcare services for pets is rising along with the number of pet owners. Pet owners are becoming more and more prepared to invest in their pets' health, which is driving up the number of veterinary appointments and operations that require efficient pain management techniques. Innovations in veterinary technology have resulted in the creation of novel and enhanced pain relief items, encompassing medications, nutritional plans, and medical apparatus. The increasing accessibility of these advancements prompts vets to implement more thorough pain management procedures, enhancing the standard of care and prolonging the lives of their patients. Furthermore, veterinary associations and animal welfare organizations' educational activities have raised public awareness about animal suffering and pain. This increased awareness prompts pet owners to look for prompt and efficient pain management solutions for their animals, which fuels the market's expansion even more. Insurance providers are also very important as these services are now more widely available to a larger audience because of growth of pet insurance policies that include coverage for pain management therapies. Pet owners have less financial strain because of this financial assistance, which motivates them to choose better pain management products. Long-term therapy solutions are in high demand since chronic illnesses, including cancer, arthritis, and post-surgical pain in dogs, are becoming more common and require constant pain management. Pharmaceutical companies are, therefore, making significant investments in R&D to produce safer and more effective animal analgesics. In conclusion, the market for veterinary pain management is expected to rise at a solid rate due to the convergence of rising chronic illness prevalence, increased awareness, expanding insurance coverage, and technological advancements.

For instance, leading animal health business, Zoetis Services LLC, introduced Solensia, a monoclonal antibody, in 2022 to help cats with osteoarthritis pain management. This cutting-edge product perfectly captures how the veterinary pain management business has been impacted by rising investments in pet healthcare. Through cutting-edge therapeutic solutions, Zoetis drove market growth by addressing a huge unmet need and offering a fresh, long-lasting pain management option.

Dominance of the NSAIDs Segment Drives Market Growth

In terms of revenue, nonsteroidal anti-inflammatory drugs (NSAIDs) hold the biggest market share and are predicted to grow at a notable CAGR during the forecast period. These medications are essential for the treatment of many different pain-related conditions in animals, including cancer and arthritis, as well as acute trauma and post-operative recovery. The best pain relief is provided by analgesics, which include both opioid and non-opioid painkillers. On the other hand, nonsteroidal anti-inflammatory drugs (NSAIDs) help to reduce inflammation and relieve pain brought on by several disorders. The need for these medications has grown as a result of the increasing frequency of these excruciating and inflammatory diseases in animals and pets, propelling market expansion. The increasing use of analgesic and anti-inflammatory drugs is indicative of a growing recognition among veterinarians and pet owners of the importance of pain management for the health and welfare of animals. More people are looking for holistic treatment for their pets, including effective pain management techniques, as the number of pet owners globally rises. Since untreated pain can significantly affect an animal's quality of life and general health, veterinarians are also taking an active approach to identifying and treating animal pain. Growing consumer knowledge is encouraging the use of a variety of painkillers, which is driving the market's expansion. Additionally, major players' endeavors, such as the introduction of new products, are accelerating the market's growth.

For example, Krka, tovarna zdravil, d.d., Novo mesto introduced Robexera, the first generic version of robenacoxib, in November 2023 to treat pain and inflammation in dogs resulting from soft tissue surgery and persistent osteoarthritis (OA).

North America Dominates the Veterinary Pain Management Market

North America holds the largest market share in the veterinary pain management market. This is because of the well-established veterinary healthcare infrastructure, the widespread use of cutting-edge technology, high disposable income, and the existence of significant businesses. These businesses' strategic actions keep boosting the expansion of the regional market. In April 2022, Zoetis Services LLC introduced AI blood smear testing for dogs and cats, enhancing its Vetscan Imagyst platform. Furthermore, the market under study is expanding due to the growing number of veterinary practitioners. For example, the U.S. Bureau of Labor Statistics stated in September 2022 that employment of veterinarians is expected to expand by 19% between 2021 and 2031, which is substantially greater than the average growth rate of all occupations. Additionally, according to the same source, there will be 4,800 expected openings for veterinarians annually on average during the next ten years. Hence, the growing number of veterinarians is fueling the demand for veterinary pain management services, which in turn is propelling the market under study's expansion. One of the main factors propelling market revenue growth in this region is the growing number of government efforts encouraging students to work in the veterinary health industry. For example, Ohio State's MPH-VPH veterinary healthcare program equips students with the public health credentials necessary to oversee zoonotic disease prevention and control initiatives across the nation.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the veterinary pain management market are the rising pet ownership, increasing prevalence of zoonotic diseases, and thus, the rising requirement for pain management services. However, the growing need to have precision medicine to maintain healthy livestock animals and pets is also going to fuel the market growth in the future. Given that technology is advancing, cutting-edge technology in the field is expected to be developed. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion. For instance, PepiPets, Inc. launched a new mobile diagnostic testing service in August 2022. Its users were able to conduct diagnostic testing for their pets at home after the new service was introduced, according to a business announcement. Pets were supposed to feel more at ease with the treatment and spend less time traveling to an in-person office visit due to PepiPets Inc.'s at-home testing service.

Key Players Landscape and Outlook

Several companies such as Zoetis Services LLC, Boehringer Ingelheim Animal Health USA Inc., Vetoquinol, Dechra Veterinary Products Limited, Merck & Co., Inc., Ceva Sante Animale, Norbrook Laboratories Limited, Chanelle Pharma Group Ltd., Fear Free, LLC, Elanco, etc. are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed veterinary pain management services, to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For instance, with the establishment of its 35th VirbacGroup subsidiary, VirbacGroup finished acquiring all the shares of its previous distributor in Slovakia and the Czech Republic in May 2023. The teams under the direction of Jakub Satrapa, the company's previous owner and general manager of the upcoming subsidiary, worked hard for years to achieve this purchase. Their new VirbacGroup subsidiary would enable them to respond to the health needs of animals in Slovakia and the Czech Republic more quickly and efficiently.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Veterinary Pain Management Market Outlook, 2017-2031F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. Market Share Analysis & Forecast
- 4.2.1. By Product
  - 4.2.1.1. Drugs
    - 4.2.1.1.1. By Type
      - 4.2.1.1.1.1. NSAIDs
      - 4.2.1.1.1.2. Opioids
      - 4.2.1.1.1.3. Local Anesthetics
      - 4.2.1.1.1.4. Alpha 2-Agonists
      - 4.2.1.1.1.5. Others
    - 4.2.1.1.2. By Route of Administration
      - 4.2.1.1.2.1. Oral
      - 4.2.1.1.2.2. Parenteral
      - 4.2.1.1.2.3. Topical
  - 4.2.1.2. Devices
    - 4.2.1.2.1. Laser Therapy Devices
    - 4.2.1.2.2. Electromagnetic Therapy Devices
- 4.2.2. By Application
  - 4.2.2.1. Joint Pain
  - 4.2.2.2. Post-Operative Pain
  - 4.2.2.3. Cancer
  - 4.2.2.4. Others
- 4.2.3. By Animal Type
  - 4.2.3.1. Companion Animals
    - 4.2.3.1.1. Dogs
    - 4.2.3.1.2. Cats
    - 4.2.3.1.3. Horses
    - 4.2.3.1.4. Others
  - 4.2.3.2. Livestock
    - 4.2.3.2.1. Cattle
    - 4.2.3.2.2. Swine
    - 4.2.3.2.3. Others
- 4.2.4. By End-user
  - 4.2.4.1. Veterinary Hospitals
  - 4.2.4.2. Veterinary Clinics
  - 4.2.4.3. Drug Stores and Pharmacies
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
- 4.3.1. By Product
- 4.3.2. By Application
- 4.3.3. By Animal Type
- 4.3.4. By End-user
- 4.3.5. By Region

5. North America Veterinary Pain Management Market Outlook, 2017-2031F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. Market Share Analysis & Forecast
- 5.2.1. By Product
  - 5.2.1.1. Drugs
    - 5.2.1.1.1. By Type
      - 5.2.1.1.1.1. NSAIDs
      - 5.2.1.1.1.2. Opioids
      - 5.2.1.1.1.3. Local Anesthetics
      - 5.2.1.1.1.4. Alpha 2-Agonists
      - 5.2.1.1.1.5. Others
    - 5.2.1.1.2. By Route of Administration
      - 5.2.1.1.2.1. Oral
      - 5.2.1.1.2.2. Parenteral
      - 5.2.1.1.2.3. Topical
  - 5.2.1.2. Devices
    - 5.2.1.2.1. Laser Therapy Devices
    - 5.2.1.2.2. Electromagnetic Therapy Devices
- 5.2.2. By Application
  - 5.2.2.1. Joint Pain
  - 5.2.2.2. Post-Operative Pain
  - 5.2.2.3. Cancer
  - 5.2.2.4. Others
- 5.2.3. By Animal Type
  - 5.2.3.1. Companion Animals
    - 5.2.3.1.1. Dogs
    - 5.2.3.1.2. Cats
    - 5.2.3.1.3. Horses
    - 5.2.3.1.4. Others
  - 5.2.3.2. Livestock
    - 5.2.3.2.1. Cattle
    - 5.2.3.2.2. Swine
    - 5.2.3.2.3. Others
- 5.2.4. By End-user
  - 5.2.4.1. Veterinary Hospitals
  - 5.2.4.2. Veterinary Clinics
  - 5.2.4.3. Drug Stores and Pharmacies
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Veterinary Pain Management Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
    - 5.3.1.1.2. By Volume
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Product
      - 5.3.1.2.1.1. Drugs
      - 5.3.1.2.1.1.1. By Type
      - 5.3.1.2.1.1.1.1. NSAIDs
      - 5.3.1.2.1.1.1.2. Opioids
      - 5.3.1.2.1.1.1.3. Local Anesthetics
      - 5.3.1.2.1.1.1.4. Alpha 2-Agonists
      - 5.3.1.2.1.1.1.5. Others
      - 5.3.1.2.1.1.2. By Route of Administration
      - 5.3.1.2.1.1.2.1. Oral
      - 5.3.1.2.1.1.2.2. Parenteral
      - 5.3.1.2.1.1.2.3. Topical
      - 5.3.1.2.1.2. Devices
      - 5.3.1.2.1.2.1. Laser Therapy Devices
      - 5.3.1.2.1.2.2. Electromagnetic Therapy Devices
    - 5.3.1.2.2. By Application
      - 5.3.1.2.2.1. Joint Pain
      - 5.3.1.2.2.2. Post-Operative Pain
      - 5.3.1.2.2.3. Cancer
      - 5.3.1.2.2.4. Others
    - 5.3.1.2.3. By Animal Type
      - 5.3.1.2.3.1. Companion Animals
      - 5.3.1.2.3.1.1. Dogs
      - 5.3.1.2.3.1.2. Cats
      - 5.3.1.2.3.1.3. Horses
      - 5.3.1.2.3.1.4. Others
      - 5.3.1.2.3.2. Livestock
      - 5.3.1.2.3.2.1. Cattle
      - 5.3.1.2.3.2.2. Swine
      - 5.3.1.2.3.2.3. Others
    - 5.3.1.2.4. By End-user
      - 5.3.1.2.4.1. Veterinary Hospitals
      - 5.3.1.2.4.2. Veterinary Clinics
      - 5.3.1.2.4.3. Drug Stores and Pharmacies
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Veterinary Pain Management Market Outlook, 2017-2031F

6.1.1. Germany
6.1.2. France
6.1.3. Italy
6.1.4. United Kingdom
6.1.5. Russia
6.1.6. Netherlands
6.1.7. Spain
6.1.8. Poland

7. Asia-Pacific Veterinary Pain Management Market Outlook, 2017-2031F

7.1.1. India
7.1.2. China
7.1.3. Japan
7.1.4. Australia
7.1.5. Vietnam
7.1.6. South Korea
7.1.7. Indonesia
7.1.8. Philippines

8. South America Veterinary Pain Management Market Outlook, 2017-2031F

8.1.1. Brazil
8.1.2. Argentina

9. Middle East and Africa Veterinary Pain Management Market Outlook, 2017-2031F

9.1.1. Saudi Arabia
9.1.2. UAE
9.1.3. South Africa
9.1.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

16.1. Market Drivers
16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

18.1. Clinical Trials
18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Zoetis Services LLC
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 21.3.2. Boehringer Ingelheim Animal Health USA Inc.
- 21.3.3. Vetoquinol
- 21.3.4. Dechra Veterinary Products Limited
- 21.3.5. Merck & Co., Inc.
- 21.3.6. Ceva Sante Animale
- 21.3.7. Norbrook Laboratories Limited
- 21.3.8. Chanelle Pharma Group Ltd.
- 21.3.9. Fear Free, LLC
- 21.3.10. Elanco

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

動物用疼痛管理の世界市場の評価：製品タイプ別、用途別、動物タイプ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Veterinary Pain Management Market Assessment, By Product, By Application, By Animal Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の動物用疼痛管理市場の見通し、2017年～2031年

第5章 北米の動物用疼痛管理市場の見通し、2017年～2031年

第6章 欧州の動物用疼痛管理市場の見通し、2017年～2031年

第7章 アジア太平洋の動物用疼痛管理市場の見通し、2017年～2031年

第8章 南米の動物用疼痛管理市場の見通し、2017年～2031年

第9章 中東・アフリカの動物用疼痛管理市場の見通し、2017年～2031年

第10章 需要供給分析

第11章 輸出入分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

第19章 特許の情勢

第20章 ケーススタディ

第21章 競合情勢

第22章 戦略的提言

第23章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Veterinary Pain Management Market Outlook, 2017-2031F

5. North America Veterinary Pain Management Market Outlook, 2017-2031F*

6. Europe Veterinary Pain Management Market Outlook, 2017-2031F

7. Asia-Pacific Veterinary Pain Management Market Outlook, 2017-2031F

8. South America Veterinary Pain Management Market Outlook, 2017-2031F

9. Middle East and Africa Veterinary Pain Management Market Outlook, 2017-2031F

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

17. Market Trends and Developments

18. Regulatory Framework and Innovation

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

22. Strategic Recommendations

23. About Us and Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の動物用疼痛管理市場の見通し、2017年～2031年

第5章北米の動物用疼痛管理市場の見通し、2017年～2031年

第6章欧州の動物用疼痛管理市場の見通し、2017年～2031年

第7章アジア太平洋の動物用疼痛管理市場の見通し、2017年～2031年

第8章南米の動物用疼痛管理市場の見通し、2017年～2031年

第9章中東・アフリカの動物用疼痛管理市場の見通し、2017年～2031年

第10章需要供給分析

第11章輸出入分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第15章価格分析

第16章市場力学

第17章市場の動向と発展

第18章規制枠組みとイノベーション

第19章特許の情勢

第20章ケーススタディ

第21章競合情勢

第22章戦略的提言

第23章お問い合わせと免責事項